Correspondence 0001213900-24-096526 from Onconetix, Inc. (ONCO)

Onconetix, Inc.
Date: Nov. 12, 2024 · CIK: 0001782107 · Accession: 0001213900-24-096526

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-282959

Date

November 12, 2024

Author

/s/ Karina M. Fedasz

Form

CORRESP

Company

Onconetix, Inc.

Letter

Onconetix, Inc.

201 E. Fifth Street, Suite 1900

Cincinnati, OH 45202

VIA EDGAR

November 12, 2024

U.S. Securities and Exchange Commission

Office of Life Sciences

Washington, D.C. 20549

Attn: Joshua Gorsky, Tim Buchmiller

Re:

Onconetix, Inc.

Registration Statement on Form S-1

Filed November 1, 2024

File No. 333-282959

Ladies and Gentleman,

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Onconetix, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 5:00 p.m. EST on Tuesday, November 12, 2024, or as soon as thereafter practicable.

Very truly yours,
/s/ Karina M. Fedasz

Show Raw Text

CORRESP
1
filename1.htm

Onconetix, Inc.

201 E. Fifth Street, Suite 1900

Cincinnati, OH 45202

VIA EDGAR

November 12, 2024

U.S. Securities and Exchange Commission

Office of Life Sciences

Washington, D.C. 20549

Attn: Joshua Gorsky, Tim Buchmiller

    Re:

    Onconetix, Inc.

    Registration Statement on Form S-1

    Filed November 1, 2024

    File No. 333-282959

Ladies and Gentleman,

Pursuant to Rule 461 under
the Securities Act of 1933, as amended, Onconetix, Inc. hereby requests acceleration of effectiveness of the above referenced Registration
Statement so that it will become effective at 5:00 p.m. EST on Tuesday, November 12, 2024, or as soon as thereafter practicable.

    Very truly yours,

    /s/ Karina M. Fedasz

    By: Karina M. Fedasz

    Title: Interim Chief Financial Officer

    cc:

    Ellenoff Grossman & Schole LLP

SecProbe.io